Fig. 3From: A novel ROS-Related chemiluminescent semiconducting polymer nanoplatform for acute pancreatitis early diagnosis and severity assessmentOptimization of the semiconducting polymer nanoparticles. (a) Schematic of the mechanism by which the ROS content was monitored by chemiluminescence. (b-c) Optimization of the surfactant to enhance the chemiluminescence intensity. (d-e) Optimization of the CPPO/PFO ratio to enhance the chemiluminescence intensity. (f-g) Optimization of the density of PFODBT to enhance the chemiluminescence intensity. (h-i) Sensitivity of the optimal concentration of SPN (CPPO/PFO = 40; 0.25 mg/mL PFO) to H2O2.Back to article page